Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity-Reference-Cited by-同舟云学术

Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity

Published:2014-12-10 Issue:4 Volume:23 Page:1130-1143
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Tang Jie¹²,Zhang Li¹,Gao Huile¹,Liu Yayuan¹,Zhang Qianyu¹,Ran Rui¹,Zhang Zhirong¹,He Qin¹

Affiliation:

1. Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and

2. Department of Pharmaceutical Engineering, School of Bioengineering, Xihua University, Chengdu, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/10717544.2014.990651

Reference60 articles.

1. Localization of P-glycoprotein at the nuclear envelope of rat brain cells

2. An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform

3. A Systematic Overview of Chemotherapy Effects in Breast Cancer

4. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy;Biomaterials Advances;2024-09

2. Photodynamic Therapy Induced Mitochondrial Targeting Strategies for Cancer Treatment: Emerging Trends and Insights;Molecular Pharmaceutics;2024-02-23

3. Multifunctional nanoparticle-mediated combining therapy for human diseases;Signal Transduction and Targeted Therapy;2024-01-01

4. Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors;International Journal of Nanomedicine;2024-01

5. Targeted Pha Microsphere Loaded Triple-Drug System with a Sustained Drug Release for Synergistic Chemotherapy and Gene Therapy;2024